The DOI matches its Crossref record; 101 of the 105 references it cites were found in a registry or an index.
Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases
Open accessAbstract
Fructose is associated with the biochemical alterations that promote the development of metabolic syndrome (MetS), nonalcoholic fatty liver disease, and type 2 diabetes. Its consumption has increased in parallel with MetS. It is metabolized by the liver, where it stimulates de novo lipogenesis. The triglycerides synthesized lead to hepatic insulin resistance and dyslipidemia. Fructose-derived advanced glycation end products (AGEs) may be involved via the Maillard reaction. Fructose has not been a main focus of glycation research because of the difficulty in measuring its adducts, and, more importantly, because although it is 10 times more reactive than glucose, its plasma concentration is only 1% of that of glucose. In this focused review, I summarize exogenous and endogenous fructose metabolism, fructose glycation, and in vitro, animal, and human data. Fructose is elevated in several tissues of diabetic patients where the polyol pathway is active, reaching the same order of magnitude as glucose. It is plausible that the high reactivity of fructose, directly or via its metabolites, may contribute to the formation of intracellular AGEs and to vascular complications. The evidence, however, is still unconvincing. Two areas that have been overlooked so far and should be actively explored include the following: 1) enteral formation of fructose AGEs, generating an inflammatory response to the receptor for AGEs (which may explain the strong association between fructose consumption and asthma, chronic bronchitis, and arthritis); and 2) inactivation of hepatic AMP-activated protein kinase by a fructose-mediated increase in methylglyoxal flux (perpetuating lipogenesis, fatty liver, and insulin resistance). If proven correct, these mechanisms would put the fructose-mediated Maillard reaction in the limelight again as a contributing factor in chronic inflammatory diseases and MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, fructose can increase AGE formation independently of glucose by increasing 𝛼-oxoaldehydes levels.[5]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[Retracted] Fructose Diet‐Induced Skin Collagen Abnormalities Are Prevented by Lipoic Acid
Thirunavukkarasu, V., Nandhini, A. T. A., & Anuradha, C. V. (2004) · Journal of Diabetes Research · doi:10.1080/154386090506148 · Cited by 36
RetractedNallasamy, P., & Anuradha, C. V. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1882-1 · Cited by 8
RetractedThe Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J., & TeKoppele, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006700200 · Cited by 979
Imamura, F., O’Connor, L., Ye, Z., Mursu, J., Hayashino, Y., Bhupathiraju, S. N., & Forouhi, N. G. (2016) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-h3576rep · Cited by 968
Sugar, Uric Acid, and the Etiology of Diabetes and Obesity
Johnson, R. J., Nakagawa, T., Sánchez‐Lozada, L. G., Shafiu, M., Sundaram, S. S., Le, M. T., Ishimoto, T., Sautin, Y. Y., & Lanaspa, M. A. (2013) · Diabetes · doi:10.2337/db12-1814 · Cited by 791
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 761
Flagged first, then by citations
4 of the 105 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–224 of 224
Li, Y. (2019) · eScholarship@McGill (McGill) · doi:10.82308/48465
Alrubaye, A., Motovali-Bashi, M., & Miroliaei, M. (2021) · Research Square · doi:10.21203/rs.3.rs-701800/v1
Maillard reaction. Pathogenic effects.
Voyer, L. E., & Alvarado, C. (2021) · SCIREA Journal of Clinical Medicine · doi:10.54647/cm32348
Gancedo, S. Q. (2001) · Dialnet (Universidad de la Rioja)
Fructose-Induced Insulin Resistance: Prospective Biochemical Mechanisms
Tamimi, L., Ahmad, M. N., & Qinna, N. A. (2021) · Jordan Journal of Agricultural Sciences · doi:10.35516/jjas.v17i4.96
Models of Diabetes in Rats: A Focus on Diabetic Neuropathy and Biomarkers
Ismail, C. A. N., & Long, I. (2022) · Biomarkers in disease · doi:10.1007/978-3-031-08014-2_56
Imunologia do Diabetes Mellitus do tipo 1 e vias de glico-oxidação relacionadas a hiperglicemia
Renzi, D. F., & Forno, G. O. D. (2023) · Research Society and Development · doi:10.33448/rsd-v12i8.42986 · Cited by 2
Impact of dietary advanced glycation end products (dAGEs) in processed foods on health
Kunnel, S., Chakraborty, I., Govindaraju, I., Mal, S. S., & Mazumder, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14042-6.00013-0
Zuyangping formula promotes skin wound healing in diabetic rats.
Junhua, M., Zhang, H., Yuling, C., Zhang, Y. L., Wang, X., Bi, S., Ai, J., & Yonggang, C. (2024) · PubMed Central · doi:10.19852/j.cnki.jtcm.2024.06.008
Wu, Q., Cheng, Y., Liu, H., Wang, Y., Li, B., & Mu, Y. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70061
Cushnie, B., Jaruchotikamol, A., Rinthong, P., Wichai, N., Chantawong, T., & Phitsaphan, K. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i8.35
Cushnie, B., Jaruchotikamol, A., Rinthong, P., Wichai, N., Chantawong, T., & Phitsaphan, K. (2025) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v9i10.72
Yadav, A., Choudhary, R., Ram, A., Nirmalkar, U., Shree, J., Paul, S. D., & Verma, V. S. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110792
Ebrahimi, Z., Shojaeian, Z., Amiri, F., Esmaillzadeh, A., Sadeghi, O., Esteghamati, A., Jahed, S. A., & Sedaghat, S. (2023) · Figshare · doi:10.6084/m9.figshare.23788391
Keshavarz, F., Zeinalabedini, M., Ebrahimpour‐Koujan, S., & Azadbakht, L. (2024) · Figshare · doi:10.6084/m9.figshare.27059033
Yang, Y.-J., Yu, Y., Lin, K., & Lu, C.-P. (2026) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbag005
Bansal, S., Burman, A., Arora, T., Vachher, M., Wali, N. M., & Kumar, B. (2026) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2025.1752493
Kang, Y. J., Chae, S., Koh, J., Song, W., Li, Y., Kim, J., Kim, H. Y., Jeong, D., Park, J.-W., Lee, E. Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.26.701899
Pengnet, S., Chonpathompikunlert, P., Suttikul, S., LEKCHAOUM, T., Sitdhipol, J., Tunsophon, S., & Malakul, W. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10942-x
Yang, L., Xiao, T., Yang, X., Yang, L., Shen, W., Huang, Z., Nie, G., Dong, C., Jin, X., Tang, Q., et al. (2026) · Foods · doi:10.3390/foods15061058
Metadata
- Authors
- Gugliucci, A.
- Affiliations
- Touro University California (US)
- Corresponding author
- Gugliucci, Alejandro
- ORCID
- Gugliucci, Alejandro
- Venue
- Advances in Nutrition
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 8
- Issue
- 1
- Pages
- 54-62
- ISSN
- 2156-5376 (ISSN-L)
- 2161-8313
- PMC
- PMC5227984
- OpenAlex
- W2572954835
- Cited by
- 225
- References
- 105
- Citations by year
- 2026: 7 · 2025: 24 · 2024: 31 · 2023: 24 · 2022: 32 · 2021: 36 · 2020: 20 · 2019: 26 · 2018: 14 · 2017: 8
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Advances in Nutrition (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Touro Scholar (Touro College) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
- Keywords
- fructose, advanced glycation end products, Maillard reaction, metabolic syndrome, non-alcoholic fatty liver disease, type 2 diabetes, hepatic insulin resistance, de novo lipogenesis, polyol pathway, methylglyoxal, AMPK, receptor for advanced glycation end products, inflammation, asthma, chronic bronchitis, arthritis, vascular complications
- MeSH terms
- Adenosine Triphosphate, Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Fructose, Humans, Obesity, Sorbitol, Uric Acid, Glycation End Products, Advanced, Metabolic Syndrome, Lipogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
